These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34950702)

  • 1. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma.
    Chen Y; Feng R; He B; Wang J; Xian N; Huang G; Zhang Q
    Front Mol Biosci; 2021; 8():777370. PubMed ID: 34950702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma.
    Hatogai K; Kitano S; Fujii S; Kojima T; Daiko H; Nomura S; Yoshino T; Ohtsu A; Takiguchi Y; Doi T; Ochiai A
    Oncotarget; 2016 Jul; 7(30):47252-47264. PubMed ID: 27322149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma.
    Wang P; Chen Y; Long Q; Li Q; Tian J; Liu T; Wu Y; Ding Z
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma.
    Koga N; Hu Q; Sakai A; Takada K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Oki E; Oda Y; Mori M
    Cancer Sci; 2021 Aug; 112(8):3018-3028. PubMed ID: 34009732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma.
    Wang Q; Feng F; Wang F; Liu Z; Liu S; Xu G; Zheng G; Guo M; Lian X; Zhang H
    J Cancer; 2018; 9(12):2224-2231. PubMed ID: 29937943
    [No Abstract]   [Full Text] [Related]  

  • 8. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
    Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
    Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8
    Chen X; Wang L; Li P; Song M; Qin G; Gao Q; Zhang Z; Yue D; Wang D; Nan S; Qi Y; Li F; Yang L; Huang L; Zhang M; Zhang B; Gao Y; Zhang Y
    Int J Cancer; 2018 Nov; 143(10):2561-2574. PubMed ID: 29981155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma.
    Peng Y; Wang L; Yang J; Wu Q; Sun X; Zhang J; Yu Y; Zhang L; Gao J; Zhou Q; Zhu H; Yin F
    Front Pharmacol; 2024; 15():1466779. PubMed ID: 39351094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma.
    Zhao JJ; Zhou ZQ; Wang P; Chen CL; Liu Y; Pan QZ; Zhu Q; Tang Y; Weng DS; Xia JC
    Cancer Manag Res; 2018; 10():6457-6468. PubMed ID: 30568505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer.
    Yan C; Huang H; Zheng Z; Ma X; Zhao G; Zhang T; Chen X; Cao F; Wei H; Dong J; Tang P; Jiang H; Wang M; Wang P; Pang Q; Zhang W
    Front Immunol; 2023; 14():1138054. PubMed ID: 37275884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
    Zhang W; Pang Q; Zhang X; Yan C; Wang Q; Yang J; Yu S; Liu X; Pan Y; Yuan Z; Wang P; Xiao Z
    Cancer Sci; 2017 Apr; 108(4):590-597. PubMed ID: 28192623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.
    Su R; Cai L; Xiong P; Liu Z; Chen S; Liu X; Lin R; Lei Z; Tian D; Su M
    J Inflamm Res; 2022; 15():1437-1456. PubMed ID: 35250293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic endothelial cell-mediated accumulation of CD177
    Ma M; Li L; Yang SH; Huang C; Zhuang W; Huang S; Xia X; Tang Y; Li Z; Zhao ZB; Chen Q; Qiao G; Lian ZX
    Oncoimmunology; 2024; 13(1):2327692. PubMed ID: 38516269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma.
    Kim R; Keam B; Kwon D; Ock CY; Kim M; Kim TM; Kim HJ; Jeon YK; Park IK; Kang CH; Kim DW; Kim YT; Heo DS
    World J Gastroenterol; 2016 Oct; 22(37):8389-8397. PubMed ID: 27729745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.